4//SEC Filing
A2A Pharmaceuticals, Inc. 4
Accession 0001859061-23-000005
CIK 0001840439other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:19 PM ET
Size
6.8 KB
Accession
0001859061-23-000005
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-05-08$33.99/sh−100,000$3,399,310→ 3,800,000 total - Sale
Common Stock
2023-05-09$34.50/sh−150,000$5,175,720→ 3,650,000 total
Footnotes (2)
- [F1]A total of 100,000 shares were sold at an average price of 33.9931 in multiple transactions in a range of 33.01 to 34.855. Details of the specific transactions are available upon request.
- [F2]A total of 150,000 shares were sold at an average price of 34.508 in multiple transactions in a range of 33.61 to 35.64. Details of the specific transactions are available upon request.
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001859061
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:19 PM ET
- Size
- 6.8 KB